Full formOrganisations
DZGstands forDabur Zandu Gilead
Full Form of DZG
What is DZG?
DZG is a joint venture formed in 2018 between Dabur India Ltd, its subsidiary Zandu, and the US biopharmaceutical company Gilead Sciences. The partnership was created to market and distribute Gilead's patented antiviral drugs—especially those for hepatitis C and HIV—within India. By leveraging Dabur and Zandu's extensive domestic distribution network alongside Gilead's cutting-edge research, DZG aimed to make life-saving medications more affordable and accessible to Indian patients. The venture played a pivotal role in reducing the cost of hepatitis C treatment in the country, dramatically expanding patient access. DZG is referenced in business and medical contexts when discussing pharmaceutical joint ventures, generic licensing, and public health initiatives in India. For competitive exams like UPSC or banking, understanding key public-private partnerships in healthcare can be relevant, as they reflect policy impacts on affordability and disease management.
DZG का फुल फॉर्म
डाबर ज़ंदू गिलीड
Example
The launch of DZG in 2018 helped bring down the price of sofosbuvir-based hepatitis C drugs in India.
DZG — frequently asked questions
What is the full form of DZG?
DZG stands for Dabur Zandu Gilead, a joint venture between Dabur India Ltd, Zandu, and Gilead Sciences.
What is DZG's purpose?
DZG was created to market and distribute Gilead's antiviral drugs, particularly for hepatitis C and HIV, in India at affordable prices.
When was DZG formed?
DZG was formed in 2018 as a strategic partnership to improve access to expensive antiviral therapies in India.